DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more


Nutrilib.com
A comprihensive source of nutritional information

A Comparative Study of the Safety and Efficacy of Face Talc Slurry and Iodopovidone for Pleurodesis

Information source: Postgraduate Institute of Medical Education and Research
Information obtained from ClinicalTrials.gov on November 03, 2008
Link to the current ClinicalTrials.gov record.

Condition(s) targeted: Malignant Pleural Effusions; Recurrent Pleural Effusions; Primary Spontaneous Pneumothorax; Secondary Spontaneous Pneumothorax

Intervention: Pleurodesis with either talc or iodopovidone (Procedure)

Phase: N/A

Status: Recruiting

Sponsored by: Postgraduate Institute of Medical Education and Research

Official(s) and/or principal investigator(s):
Dheeraj Gupta, MD, DM, FCCP, Principal Investigator, Affiliation: Additional Professor, Dept of Pulmonary Medicine, PGIMER, Chandigarh, India

Summary

Pleurodesis is a technique used to fuse the two layers of the lining over the lung. This is done to get rid of collections of fluid or air in this space. A common reason would be cancer of the underlying lung or elsewhere causing fluid to collect in the pleural space. In this situation it is a palliative procedure to free the patient from symptoms like breathlessness.

Clinical Details

Official title: A Comparative Study of the Safety and Efficacy of Face Talc Slurry and Iodopovidone for Pleurodesis

Study design: Treatment, Randomized, Open Label, Active Control, Parallel Assignment, Safety/Efficacy Study

Primary outcome:

Success

Failure

Secondary outcome:

Death

Pain by VAS

Time to Pleurodesis

Others

Detailed description: Pleurodesis is a technique used to fuse the two layers of the pleura. This is done to prevent reaccumulation of collections of fluid or air in this space. Common indications are malignant pleural effusions, recurrent pneumothorax and even benign effusions which are otherwise difficult to eradicate.

Eligibility

Minimum age: 12 Years. Maximum age: N/A. Gender(s): Both.

Criteria:

Inclusion Criteria:

- Age over 12 years

- Symptomatic recurrent pleural effusion

- Pneumothorax needing pleurodesis

Exclusion Criteria:

- Life expectancy <1 month

- Unwilling to give consent

- Empyema

- ICTD drain output >150 ml/d

- Presence of an airleak

Locations and Contacts

PGIMER, Chandigarh 160 012, India; Recruiting
Abinash Paul, MD, Phone: 91-9417745955, Email: draspaul@yahoo.co.in
Ritesh Agarwal, MD DM, Phone: 91- 9815799226, Email: ritesh@indiachest.org
Additional Information

Starting date: January 2006
Ending date: December 2007
Last updated: February 1, 2007

Page last updated: November 03, 2008

-- advertisement -- The American Red Cross

We comply with
HONcode standard.
Verify here.
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2008